Yes, start oral cephalexin and obtain the recommended diagnostic workup for this suspected cellulitis.
For a patient with painful unilateral foot swelling, erythema, bruising, and inability to ambulate, you should initiate oral cephalexin and obtain a complete blood count, basic metabolic panel, inflammatory markers (ESR/CRP), and foot/ankle radiographs to evaluate for cellulitis and rule out underlying osteomyelitis.
Diagnostic Approach
Clinical Diagnosis
The presentation of unilateral foot swelling with erythema, pain, and functional impairment meets clinical criteria for cellulitis, which requires at least two signs of inflammation: erythema, warmth, tenderness/pain, or swelling 1. The unilateral nature is important—bilateral lower extremity erythema and swelling should prompt consideration of non-infectious etiologies like venous stasis dermatitis or contact dermatitis 2.
Laboratory Testing
Obtain blood work including:
- Complete blood count (WBC with differential)
- Basic metabolic panel (to assess renal function for antibiotic dosing)
- Inflammatory markers (ESR and CRP)
While WBC counts and inflammatory markers have limited utility for monitoring treatment response 3, markedly elevated ESR is suggestive of underlying osteomyelitis in suspected cases 1. These baseline values provide important context, particularly if the patient fails to improve.
Imaging Studies
Plain radiographs of the foot and ankle are essential 1. The guidelines are clear: obtain plain X-rays in all cases of non-superficial diabetic foot infections 1, and this principle extends to any foot infection where osteomyelitis is a consideration. Given the inability to ambulate and the presence of bruising (which could indicate deeper tissue involvement), ruling out bone involvement is critical.
If initial radiographs are negative but clinical suspicion for osteomyelitis persists after 2 weeks of soft tissue treatment, repeat radiography in 2-4 weeks 3. MRI is the most accurate imaging modality for defining bone infection and deep soft-tissue infections 3 but is not needed as first-line investigation in most cases.
Antibiotic Selection
Why Cephalexin is Appropriate
Cephalexin is an appropriate first-line agent for mild to moderate non-purulent cellulitis 3. The diabetic foot infection guidelines specifically list cephalexin as suitable for mild infections 3, and it provides coverage against the most common pathogens: Staphylococcus aureus and β-hemolytic streptococci 4.
Dosing Considerations
Standard dosing is 500 mg orally four times daily 5. However, emerging evidence suggests higher doses may be beneficial. A 2023 pilot RCT found that high-dose cephalexin (1000 mg four times daily) had fewer treatment failures (3.2%) compared to standard-dose (12.9%), though with more minor adverse effects 6. For more severe infections or those caused by less susceptible organisms, larger doses may be needed 5.
MRSA Coverage Considerations
The question of MRSA coverage is nuanced. For non-purulent cellulitis without systemic signs, streptococci are the presumed predominant pathogens, and anti-streptococcal therapy alone (like cephalexin) is appropriate 7, 4. However, if there are concerning features—purulent drainage, penetrating trauma, systemic inflammatory response syndrome (SIRS), or known MRSA colonization—then coverage with agents like trimethoprim-sulfamethoxazole or vancomycin should be added 7.
A 2017 RCT comparing cephalexin alone versus cephalexin plus trimethoprim-sulfamethoxazole for uncomplicated cellulitis found no significant difference in clinical cure rates in the per-protocol analysis (83.5% vs 85.5%) 8. Conversely, a 2010 study from Hawaii (high MRSA prevalence area) found trimethoprim-sulfamethoxazole had significantly higher success rates than cephalexin (91% vs 74%) 9. The key is local epidemiology and clinical severity—in areas with high community-acquired MRSA prevalence or with moderate-to-severe infection, consider adding MRSA coverage.
Treatment Duration and Monitoring
Duration
For soft tissue infection only, treat for 1-2 weeks, extending up to 4 weeks if slow to resolve 3. The standard recommendation is 5 days minimum, with extension if infection has not improved 7.
Follow-up
Outpatients should be reassessed every 2-5 days initially 3. Primary indicators of improvement are resolution of local symptoms (erythema, warmth, swelling, tenderness) and systemic symptoms 3.
Critical Pitfalls to Avoid
Missing osteomyelitis: The inability to walk and presence of bruising raise concern for deeper involvement. If plain films show cortical erosion, periosteal reaction, or mixed lucency/sclerosis, treat for presumptive osteomyelitis (4-6 weeks of antibiotics) 3.
Misdiagnosing cellulitis: Up to 30% of suspected cellulitis cases are misdiagnosed 4. Consider alternative diagnoses like venous stasis dermatitis, contact dermatitis, or gout, especially if bilateral or lacking acute onset.
Inadequate source control: If there is an underlying abscess or deep collection, antibiotics alone are insufficient—surgical drainage is required 7, 10.
Ignoring vascular status: The presence of peripheral arterial disease significantly complicates both diagnosis and treatment 1. Assess for adequate perfusion.
Failure to address predisposing factors: Evaluate for interdigital toe space infections (tinea pedis), edema, or underlying wounds that may serve as portals of entry 7.